2022中国结核病预防性治疗指南

标题: 2022中国结核病预防性治疗指南
title: 2022 Guidelines for Preventive Treatment of Tuberculosis in China
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 本指南适用于各级医疗机构。本指南供结核科医师、感染科医生、风湿免疫科医师、器官移植科医师、血透科医师及与LTBI诊疗和管理相关的专业医护人员使用
Guide users: This guideline applies to all levels of medical institutions. This guideline is intended for use by TB physicians, infectious disease physicians, rheumatologists, transplant physicians, hemodialysis physicians, and healthcare professionals associated with the diagnosis and management of LTBI.
证据分级方法: GRADE method of grading evidence
Evidence grading method: GRADE证据分级方法
制定单位: 中华医学会结核病学分会;国家感染性疾病临床医学研究中心;深圳市第三人民医院
Formulating unit: Tuberculosis Branch of Chinese Medical Association; National Clinical Research Center for Infectious Diseases; Shenzhen Third People's Hospital
注册时间: 2022-05-08
Registration time:
注册编号: IPGRP-2022CN256
Registration number:
指南制订的目的: 建立中国潜伏结核感染预防干预和管理,以期指导临床医师和相关护理人员,推动中国潜伏结核感染的控制与管理
Purpose of the guideline: Establish the prevention, intervention and management of latent tuberculosis infection in China, in order to guide clinicians and relevant nursing staff to promote the control and management of latent tuberculosis infection in China.